EUVIMEDEUVIMED entdecken
Crossref

Exploration of novel costunolide derivatives bearing indole/indoline as anti-ulcerative colitis agents by targeting JAK2-STAT3 pathways

Hengli Yang, Yuan Jiang, Ruijuan Yang, Zhengxiao Huang, Zewei Mao, Yanping Li

Bioorganic Chemistry · 2026

DOI: 10.1016/j.bioorg.2026.109910 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026. Verfasst von Hengli Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming 650500, PR China. Hauptthemen laut MEDLINE: Janus Kinase 2, STAT3 Transcription Factor, Indoles, Colitis, Ulcerative. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Applied Basic Research Foundation of Yunnan Province, Yunnan Province Department of Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ulcerative colitis (UC) is a kind of hard to cure chronic inflammatory disease. In present work, a series of new costunolide derivatives bearing indole/indoline have been prepared, and anti-inflammatory activities and mechanism have been tested. The results indicated that costunolide derivatives displayed good inhibition of NO generation. The in vivo studies showed that 4c exerted good protective effects in DSS-induced UC mice model by inhibiting the expression of IL-17 A and IL-17F, reducing the infiltration of immune cells, and inhibiting the phosphorylation of JAK2-STAT3 tyrosine residues. Therefore, new costunolide derivatives could be considered as potential JAK2/STAT3 pathway modulator for treatment of UC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Janus Kinase 2STAT3 Transcription FactorIndolesColitis, UlcerativeSesquiterpenesAnti-Inflammatory Agents, Non-SteroidalAnimalsMiceMolecular StructureStructure-Activity RelationshipDose-Response Relationship, DrugDextran SulfateSignal TransductionHumansMolecular Docking SimulationLactones

Stichwörter der Autor:innen

CostunolideJAK2-STAT3 pathwaysMolecular dockingUlcerative colitis

Substanzen

Janus Kinase 2STAT3 Transcription FactorIndolescostunolideSesquiterpenesAnti-Inflammatory Agents, Non-SteroidalindoleDextran SulfateLactones

Autor:innen und Institutionen

  • School of Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming 650500, PR China.
  • School of Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming 650500, PR China; Yunnan Key Laboratory of Dai and Yi Medicines, Yunnan University of Chinese Medicine, Kunming 650500, PR China; Diqing T…
  • School of Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming 650500, PR China. Electronic address: maozw@ynucm.edu.cn.
  • School of Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming 650500, PR China. Electronic address: lyp8691@163.com.

Förderung

  • National Natural Science Foundation of China
  • Applied Basic Research Foundation of Yunnan Province
  • Yunnan Province Department of Education
  • Yunnan Provincial Science and Technology Department

Zitieren

APA

Yang, H., Jiang, Y., Yang, R., Huang, Z., Mao, Z., & Li, Y. (2026). Exploration of novel costunolide derivatives bearing indole/indoline as anti-ulcerative colitis agents by targeting JAK2-STAT3 pathways. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2026.109910

Vancouver

Yang H, Jiang Y, Yang R, Huang Z, Mao Z, Li Y. Exploration of novel costunolide derivatives bearing indole/indoline as anti-ulcerative colitis agents by targeting JAK2-STAT3 pathways. Bioorganic Chemistry. 2026. doi:10.1016/j.bioorg.2026.109910

BibTeX
@article{Yang2026,
  author = {Yang, Hengli and Jiang, Yuan and Yang, Ruijuan and Huang, Zhengxiao and Mao, Zewei and Li, Yanping},
  title = {Exploration of novel costunolide derivatives bearing indole/indoline as anti-ulcerative colitis agents by targeting JAK2-STAT3 pathways},
  journal = {Bioorganic Chemistry},
  year = {2026},
  doi = {10.1016/j.bioorg.2026.109910}
}
Kostenlos starten →